Advanced Enzyme Technologies Shares Surge 10.9% on Heavy Buying Interest in Biotech Sector

Mumbai, August 29, 2025: The shares of Advanced Enzyme Technologies Limited (NSE: ADVENZYMES, BSE: 540025) continued to rise for the second consecutive day and jumped by 10.94% to ₹359.60 in early trade on Friday. The stock had also outperformed the broader sector by 7.42% on Thursday when it surged by 8.82% and reached an intraday high of ₹828.80.

The increased interest of investors is attributed to the company’s stellar performance in the pharmaceutical and biotech industry, which led to strong buying volumes and a favourable demand-supply gap in the order book.

Leading Indian Biotech Firm Specialising in Enzymes for Healthcare, Nutrition, and Industrial Applications

Headquartered in Mumbai and listed on NSE & BSE, Advanced Enzyme Technologies develops enzymes for human healthcare, animal nutrition, and industrial applications. The firm’s diversified product portfolio and sector leadership underpin its market relevance and investor interest.

Investor Appetite Drives Stock Up ₹35 to ₹359.60 Amid High Demand-Supply Imbalance

Advanced Enzyme’s stock surged 10.94% to ₹359.60, supported by strong demand with over 77 lakh buy orders versus just 5 lakh sell orders. The stock traded between ₹318.05 and ₹363.55, with a VWAP of ₹350.63 and turnover of ₹114.61 crore on 32.67 lakh shares. It remains well above its 52-week low of ₹257.90 but below the high of ₹571. With daily volatility at 2.45% and an annualized rate of 46.81%, the sentiment indicates a clear positive bias.

Share Gains 37% in Six Months, P/E Stands at 26.49 vs Industry Average 34.66

Following today’s surge, the company’s stock has increased by nearly 37% over the past six months. However, from a YTD perspective, the returns have been quite low (1.35%), and the share has failed to beat the broad sectoral averages. The stock trades at a P/E of 26.49, indicating relative undervaluation compared to the industry’s 34.66.

REF: https://www.nseindia.com/get-quotes/equity?symbol=ADVENZYMES

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations